Lu X, Yu R, Li Z, Yang M, et al. JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers. Cancer Lett 2024;582:216517.
PMID: 38101609